M&A Deal Summary

Sanfer Acquires Vitalis

On January 18, 2024, Sanfer acquired life science company Vitalis from ACON Investments

Acquisition Highlights
  • This is Sanfer’s 1st transaction in the Life Science sector.
  • This is Sanfer’s 1st transaction in Colombia.

M&A Deal Summary
Date 2024-01-18
Target Vitalis
Sector Life Science
Buyer(s) Sanfer
Sellers(s) ACON Investments
Deal Type Add-on Acquisition

Target

Vitalis

Bogota, Colombia
Vitalis is a manufacturer and wholesaler of generic injectable pharmaceuticals with production facilities in Colombia and Mexico. Vitalis is based in Bogota, Colombia.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sanfer

Tlacopac, Mexico
Category Company
Sector Life Science
DESCRIPTION

Sanfer is an independent pharmaceutical companies in Mexico, operating in nine countries across Latin America. Sanfer manufactures, markets and sells prescription and over the counter branded medications across five therapeutic areas including gastroenterology, cardiology, anti-infective, and dermatology. Sanfer is based in Tlacopac, Mexico.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Colombia) 1 of 1
Year (2024) 1 of 1

Seller(S) 1

SELLER

ACON Investments

Washington, District of Columbia, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1996
PE ASSETS 7.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

ACON Investments is an international private equity firm that targets investments in the US, Europe, and Latin America. ACON's investment strategy covers 'opportunities at times of change - responding at points of inflection where value creation is possible'. Examples include businesses that serve the rapidly growing US Hispanic population, energy and energy service needs, businesses in need of operational help, and opportunities in Latin America resulting from economic deregulation and political liberalization. ACON's looks for companies where it can commit $20 to $150 million of equity capital. Target sectors include consumer products and services, distribution, business services and industrial manufacturing. ACON Investments was formed in 1996 and has offices in Washington DC; Houston, Texas; Los Angeles, California; and Madrid, Spain.

DEAL STATS #
Overall 27 of 31
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 16 of 16
Country (Colombia) 2 of 2
Year (2024) 1 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-07-24 Dori Alimentos

Marilia, Brazil

Dori Alimentos is a manufacturer and distributor of snack and candy products. The company's snacks include peanuts, chocolates, gummies, hard and chewy candies, lollipops, among others. Its portfolio also includes brands known in the Brazilian market and synonymous with their categories, such as Dori, Pettiz, Gomets, Bolete, Yogurte 100, Chococandy, and Disqueti.Dori Alimentos was founded in 1967 and is based in Marilia, Brazil.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-06-25 BioMatrix Specialty Pharmacy

Plantation, Florida, United States

BioMatrix Specialty Pharmacy offers a comprehensive pharmacy with a wide range of services across hemophilia, transplantation, specialty, and digital health technology solutions. BioMatrix Specialty Pharmacy is a provider for patients with blood disorders, organ transplants and other chronic and acute diseases and conditions. BioMatrix Specialty Pharmacy was founded in 2015 and is based in Plantation, Florida.

Sell -
Mergr

Product

Company

Legal